Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Illumina, Inc.
Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.
IPO Date: July 28, 2000
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $15.71B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.14 | 1.71%
Avg Daily Range (30 D): $1.24 | 1.33%
Avg Daily Range (90 D): $1.49 | 1.81%
Institutional Daily Volume
Avg Daily Volume: 1.24M
Avg Daily Volume (30 D): 1.81M
Avg Daily Volume (90 D): 1.87M
Trade Size
Avg Trade Size (Sh.): 87
Avg Trade Size (Sh.) (30 D): 49
Avg Trade Size (Sh.) (90 D): 52
Institutional Trades
Total Inst.Trades: 24,220
Avg Inst. Trade: $6.86M
Avg Inst. Trade (30 D): $9.54M
Avg Inst. Trade (90 D): $6.78M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 5
Market Closing Trades
Avg Closing Trade: $20.22M
Avg Closing Trade (30 D): $35.25M
Avg Closing Trade (90 D): $27.58M
Avg Closing Volume: 111.94K
   
News
Jun 21, 2025 @ 12:00 PM
Long Read Sequencing Market Projected to Reach USD...
Source: Sns Insider
Jun 16, 2025 @ 8:00 PM
Saudia Arabia Introduces Strategic Healthcare Visi...
Source: Riyadh, Kingdom Of Saudi Arabia
Jun 12, 2025 @ 8:58 AM
Molecular Diagnostics for Cancer Market Research 2...
Source: Researchandmarkets.Com
Jun 6, 2025 @ 9:36 AM
Companion Diagnostic Markets Report 2025-2029: Dia...
Source: Researchandmarkets.Com
Jun 4, 2025 @ 2:58 PM
Forensic Genomics Market Research 2025 - Global Tr...
Source: Researchandmarkets.Com
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-6.05 $.83 $1.17
Diluted EPS $-6.07 $.82 $1.17
Revenue $ 4.34B $ 1.04B $ 1.1B
Gross Profit $ 2.88B $ 683M $ 728M
Net Income / Loss $ -966M $ 131M $ 187M
Operating Income / Loss $ -557M $ 164M $ 175M
Cost of Revenue $ 1.46B $ 358M $ 376M
Net Cash Flow $ 5M $ -14M $ 258M
PE Ratio    
Splits
Sep 23, 2008:   2:1